Bone Biologics (NASDAQ:BBLGW) Stock Price Down 28.1% – Should You Sell?

Shares of Bone Biologics Co. (NASDAQ:BBLGW) dropped 28.1% during mid-day trading on Friday . The company traded as low as $8.30 and last traded at $10.79. Approximately 400 shares changed hands during mid-day trading, a decline of 78% from the average daily volume of 1,843 shares. The stock had previously closed at $15.00.

Bone Biologics Trading Down 28.1%

The company has a fifty day moving average of $12.95 and a 200 day moving average of $15.69.

Bone Biologics Company Profile

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1.